NCT02190786View on ClinicalTrials.gov

Phase II Exploratory Clinical Study of KUX-1151

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

March 31, 2015

Conditions
Hyperuricemia
Interventions
DRUG

KUX-1151

Trial Locations (1)

Unknown

Tokyo and Other Japanese City

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT02190786 - Phase II Exploratory Clinical Study of KUX-1151 | Biotech Hunter | Biotech Hunter